The $510 million acquisition of YM BioSciences is a low-risk deal for the big biotech, and has Incyte shareholders worried.
Stocks add to earlier gains as Fed announces plans to continue stimulus measures.
These stocks are supported by both solid fundamentals and strong technical positions.
But expect the Affordable Care Act and prescriber pushback to curb drug-pricing power.
New data are significant as the biotech company moves closer to filing for approval of Sofosbuvir next year.
Clinical trials, drug launches and FDA approval decisions fill the calendar for these companies at the start of the new year.
Next-gen drugs can help power growth and income alike.
VIDEO ON MSN MONEY
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
Investors know what's working and what's not. These stocks could power higher through the end of the year.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Six weeks later, most Americans have forgotten about the 2014 tax season -- except those who didn't file by the April 15 deadline.
MUST-SEE ON MSN
- Video: Easy DIY smoked meats at home
A charcuterie master shares his process for cold-smoking meat at home.
- Jetpacks about to go mainstream
- Weird things covered by home insurance
- Bing: 70 percent of adults report 'digital eye strain'